Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Recovery and prognostic value of myocardial strain in ST-segment elevation myocardial infarction patients with a concurrent chronic total occlusion.

Elias J, van Dongen IM, Hoebers LP, Ouweneel DM, Claessen BEPM, Råmunddal T, Laanmets P, Eriksen E, Piek JJ, van der Schaaf RJ, Ioanes D, Nijveldt R, Tijssen JG, Henriques JPS, Hirsch A; EXPLORE investigators.

Eur Radiol. 2019 Jul 26. doi: 10.1007/s00330-019-06338-x. [Epub ahead of print]

PMID:
31350585
2.

Bioresorbable vascular scaffold versus Xience metallic stents: outcomes in the AIDA trial stratified by SYNTAX score.

Kraak RP, Tijssen RYG, van Dongen IM, Elias J, Hofma SH, van der Schaaf RJ, Arkenbout EK, Weevers A, Tijssen JGP, Piek JJ, de Winter RJ, Henriques JPS, Wykrzykowska JJ; Collaborators.

EuroIntervention. 2019 May 7. pii: EIJ-D-18-00884. doi: 10.4244/EIJ-D-18-00884. [Epub ahead of print]

3.

Exercise testing after chronic total coronary occlusion revascularization in patients with STEMI and a concurrent CTO: A subanalysis of the EXPLORE-trial.

van Veelen A, van Dongen IM, Elias J, Råmunddal T, Eriksen E, van der Schaaf RJ, Claessen BEPM, Postema PG, Henriques JPS.

Catheter Cardiovasc Interv. 2019 Apr 9. doi: 10.1002/ccd.28282. [Epub ahead of print]

PMID:
30968546
4.

Value of the SYNTAX Score in ST-Elevation Myocardial Infarction Patients With a Concomitant Chronic Total Coronary Occlusion(from the EXPLORE Trial).

van Dongen IM, Elias J, García-García HM, Hoebers LP, Ouweneel DM, Scheunhage EM, Delewi R, Råmunddal T, Eriksen E, Claessen BE, van der Schaaf RJ, Henriques JPS; EXPLORE investigators.

Am J Cardiol. 2019 Apr 1;123(7):1035-1043. doi: 10.1016/j.amjcard.2018.12.028. Epub 2019 Jan 4.

5.

The effect of revascularization of a chronic total coronary occlusion on electrocardiographic variables. A sub-study of the EXPLORE trial.

van Dongen IM, Kolk MZH, Elias J, Meijborg VMF, Coronel R, de Bakker JMT, Claessen BEPM, Delewi R, Ouweneel DM, Scheunhage EM, van der Schaaf RJ, Suttorp MJ, Bax M, Marques KM, Postema PG, Wilde AAM, Henriques JPS.

J Electrocardiol. 2018 Sep - Oct;51(5):906-912. doi: 10.1016/j.jelectrocard.2018.07.012. Epub 2018 Jul 19.

6.

Impact of collateralisation to a concomitant chronic total occlusion in patients with ST-elevation myocardial infarction: a subanalysis of the EXPLORE randomised controlled trial.

van Dongen IM, Elias J, van Houwelingen KG, Agostoni P, Claessen BEPM, Hoebers LP, Ouweneel DM, Scheunhage EM, Delewi R, Piek JJ, Råmunddal T, Laanmets P, Eriksen E, Bax M, Suttorp MJ, van der Schaaf RJ, Tijssen JGP, Henriques JPS.

Open Heart. 2018 Jul 16;5(2):e000810. doi: 10.1136/openhrt-2018-000810. eCollection 2018.

7.

Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI.

Tijssen RYG, Kraak RP, Hofma SH, van der Schaaf RJ, Arkenbout EK, Weevers A, Elias J, van Dongen IM, Koch KT, Baan J Jr, Vis M, de Winter RJ, Piek JJ, Tijssen JGP, Henriques JPS, Wykrzykowska JJ.

EuroIntervention. 2018 Jul 20;14(4):e426-e433. doi: 10.4244/EIJ-D-18-00335.

8.

Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long-Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator (the eCTOpy-in-ICD Study).

van Dongen IM, Yilmaz D, Elias J, Claessen BEPM, Delewi R, Knops RE, Wilde AAM, van Erven L, Schalij MJ, Henriques JPS.

J Am Heart Assoc. 2018 May 2;7(10). pii: e008609. doi: 10.1161/JAHA.118.008609.

9.

Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial.

Tijssen RYG, Kraak RP, Elias J, van Dongen IM, Kalkman DN, Nassif M, Sotomi Y, Asano T, Katagiri Y, Collet C, Piek JJ, Henriques JPS, de Winter RJ, Tijssen JGP, Onuma Y, Serruys PW, Wykrzykowska JJ.

EuroIntervention. 2018 Jul 20;14(4):e434-e442. doi: 10.4244/EIJ-D-17-01152.

10.

Collateral Quality Decay Several Days After Primary Percutaneous Coronary Intervention: A Unique Observation From the EXPLORE Trial.

van Dongen IM, Elias J, van Houwelingen G, Agostoni P, Hoebers LP, Ouweneel DM, Delewi R, Claessen BEPM, van der Schaaf RJ, Henriques JPS; EXPLORE investigators.

JACC Cardiovasc Interv. 2018 Mar 12;11(5):511-512. doi: 10.1016/j.jcin.2017.11.033. No abstract available.

11.

Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.

Elias J, van Dongen IM, Råmunddal T, Laanmets P, Eriksen E, Meuwissen M, Michels HR, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Marques KM, Claessen BEPM, Hirsch A, van der Schaaf RJ, Tijssen JGP, Henriques JPS, Hoebers LP; EXPLORE investigators.

Heart. 2018 Sep;104(17):1432-1438. doi: 10.1136/heartjnl-2017-312698. Epub 2018 Feb 20.

PMID:
29463612
12.

Electrocardiographic changes after successful recanalization of a chronic total coronary occlusion. A systematic review and meta-analysis.

van Dongen IM, Elias J, Meijborg VMF, De Bakker JMT, Limpens J, Conrath CE, Henriques JPS.

Cardiovasc Revasc Med. 2018 Mar;19(2):221-228. doi: 10.1016/j.carrev.2017.09.004. Epub 2017 Sep 12.

PMID:
29066338
13.

The first-generation ABSORB BVS: awaiting dissolving outcomes.

Elias J, van Dongen IM, Henriques JPS.

Neth Heart J. 2017 Nov;25(11):650-652. doi: 10.1007/s12471-017-1042-8. No abstract available.

14.

Improved recovery of regional left ventricular function after PCI of chronic total occlusion in STEMI patients: a cardiovascular magnetic resonance study of the randomized controlled EXPLORE trial.

Elias J, van Dongen IM, Hoebers LP, Ouweneel DM, Claessen BEPM, Råmunddal T, Laanmets P, Eriksen E, van der Schaaf RJ, Ioanes D, Nijveldt R, Tijssen JG, Hirsch A, Henriques JPS; EXPLORE investigators.

J Cardiovasc Magn Reson. 2017 Jul 19;19(1):53. doi: 10.1186/s12968-017-0369-z.

15.

Mid-term and long-term safety and efficacy of bioresorbable vascular scaffolds versus metallic everolimus-eluting stents in coronary artery disease: A weighted meta-analysis of seven randomised controlled trials including 5577 patients.

Elias J, van Dongen IM, Kraak RP, Tijssen RYG, Claessen BEPM, Tijssen JGP, de Winter RJ, Piek JJ, Wykrzykowska JJ, Henriques JPS.

Neth Heart J. 2017 Jul;25(7-8):429-438. doi: 10.1007/s12471-017-1008-x.

16.

Impact of Chronic Total Occlusion Location on LV Function in ST-Segment Elevation Myocardial Infarction Patients.

Elias J, Hoebers LP, van Dongen IM, Claessen BEPM, van der Schaaf RJ, Tijssen JG, Hirsch A, Henriques JPS; EXPLORE Investigators.

J Am Coll Cardiol. 2017 May 9;69(18):2347-2348. doi: 10.1016/j.jacc.2017.02.054. No abstract available.

17.

Impact of Collateral Circulation on Survival in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention With a Concomitant Chronic Total Occlusion.

Elias J, Hoebers LPC, van Dongen IM, Claessen BEPM, Henriques JPS.

JACC Cardiovasc Interv. 2017 May 8;10(9):906-914. doi: 10.1016/j.jcin.2017.01.026.

18.

Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.

Wykrzykowska JJ, Kraak RP, Hofma SH, van der Schaaf RJ, Arkenbout EK, IJsselmuiden AJ, Elias J, van Dongen IM, Tijssen RYG, Koch KT, Baan J Jr, Vis MM, de Winter RJ, Piek JJ, Tijssen JGP, Henriques JPS; AIDA Investigators.

N Engl J Med. 2017 Jun 15;376(24):2319-2328. doi: 10.1056/NEJMoa1614954. Epub 2017 Mar 29.

19.

Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction.

Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJ, Vis MM, Wykrzykowska JJ, Koch KT, Baan J, de Winter RJ, Piek JJ, Lagrand WK, de Mol BA, Tijssen JG, Henriques JP.

J Am Coll Cardiol. 2017 Jan 24;69(3):278-287. doi: 10.1016/j.jacc.2016.10.022. Epub 2016 Oct 31.

20.

Meta-analyses and randomized trials investigating percutaneous coronary intervention of chronic total occlusions: what is left to explore?

Claessen BE, Hoebers LP, Elias JE, van Dongen IM, Henriques JP.

J Thorac Dis. 2016 Sep;8(9):E1100-E1102. No abstract available.

21.

Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial.

Henriques JP, Hoebers LP, Råmunddal T, Laanmets P, Eriksen E, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Nijveldt R, van Rossum AC, Marques KM, Elias J, van Dongen IM, Claessen BE, Tijssen JG, van der Schaaf RJ; EXPLORE Trial Investigators.

J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632. doi: 10.1016/j.jacc.2016.07.744.

22.

The impact of the location of a chronic total occlusion in a non-infarct-related artery on long-term mortality in ST-elevation myocardial infarction patients.

Hoebers LP, Elias J, van Dongen IM, Ouweneel DM, Claessen BE, Piek JJ, Henriques JP.

EuroIntervention. 2016 Jul 20;12(4):423-30. doi: 10.4244/EIJV12I4A75.

23.

Severe mitral regurgitation caused by eosinophilic endocarditis.

van Dongen IM, van Kraaij DJW, Schalla S, Brunner-La Rocca HP, Driessen RGH.

J Cardiol Cases. 2014 Jul 7;10(3):108-110. doi: 10.1016/j.jccase.2014.05.012. eCollection 2014 Sep.

Supplemental Content

Loading ...
Support Center